Security Snapshot

ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI) Institutional Ownership

CUSIP: 903899102

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

52

Shares (Excl. Options)

5.34MFull value: 5,342,399 · shares · 30 Jun 2026

Price

$6.32

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+16,332
Value change
+$103,217
Number of holders
52
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
16,666,558
SEC-reported price per share
$6.46
Insider filing price
$6.46
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ULBI - ULTRALIFE CORP - Common Stock, $.10 par value per share is tracked under CUSIP 903899102.
  • 52 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 50 to 52 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $34.72MFull value: $34,724,476 · USD · 31 Mar 2026
    to
    $33.76MFull value: $33,761,034 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 52 institutions filings for Q2 2026.

Open SEC evidence

Security key

903899102

13F reference period

Q2 2026

13F holders

52

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
ULBI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WHITMORE BRADFORD T 40% $37,751,754 6,599,957 WHITMORE BRADFORD T 12 Mar 2026
Visionary Wealth Advisors 6.6% -15% $6,235,984 -$1,159,038 1,090,207 -16% Visionary Wealth Advisors 31 Dec 2025
As of 30 Jun 2026, 52 institutional investors reported holding
5.34MFull value: 5,342,399 · shares · 30 Jun 2026
shares of ULTRALIFE CORP - Common Stock, $.10 par value per share (ULBI). This represents 32% of the company’s total
16.67MFull value: 16,666,558 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
31%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Visionary Wealth Advisors 6.7% 1,109,170 +0.27% 0.28% $7,009,955
DIMENSIONAL FUND ADVISORS LP 5.8% 963,733 -3.1% 0% $6,090,519
Janney Montgomery Scott LLC 3.4% 560,350 +8.2% 0.01% $3,541,000
VANGUARD CAPITAL MANAGEMENT LLC 2.8% 464,730 +1.5% 0% $2,937,094
Truffle Hound Capital, LLC 1.5% 250,000 0% 1% $1,580,000
RBF Capital, LLC 1.3% 218,714 0% 0.06% $1,382,272
RENAISSANCE TECHNOLOGIES LLC 1% 171,790 -13% 0% $1,085,713
Connor, Clark & Lunn Investment Management Ltd. 0.93% 155,043 +0.01% 0% $979,872
BlackRock, Inc. 0.93% 154,406 +5.6% 0% $975,845
RAYMOND JAMES FINANCIAL INC 0.82% 136,696 -1.9% 0% $863,919
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.76% 126,753 0% 0% $801,079
GEODE CAPITAL MANAGEMENT, LLC 0.75% 125,776 -1.2% 0% $795,477
Teton Advisors, LLC 0.65% 109,000 0% 0.4% $688,880
ACADIAN ASSET MANAGEMENT LLC 0.5% 83,799 0% 0% $528,000
Russell Investments Group, Ltd. 0.43% 72,490 -11% 0% $458,140
VANGUARD FIDUCIARY TRUST CO 0.38% 63,496 +0.68% 0% $401,295
LSV ASSET MANAGEMENT 0.38% 63,050 -2.2% 0% $398,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.36% 59,579 0% 0.01% $376,539
Ancora Advisors LLC 0.34% 56,169 0% 0.01% $354,988
TWO SIGMA INVESTMENTS, LP 0.31% 51,106 -18% 0% $322,990
Maridea Wealth Management LLC 0.26% 42,708 0.03% $269,915
STATE STREET CORP 0.25% 42,470 -0.82% 0% $268,410
AMERIPRISE FINANCIAL INC 0.22% 36,521 +1% 0% $230,812
Man Group plc 0.2% 33,727 +46% 0% $213,155
CITADEL ADVISORS LLC 0.15% 25,283 -39% 0% $159,789

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 7,700 $49,742 +$8,541 $6.46 4
2026 Q2 5,342,399 $33,761,034 +$103,217 $6.32 52
2026 Q1 5,326,090 $34,724,476 -$1,299,303 $6.52 50
2025 Q4 5,611,465 $32,094,777 -$557,686 $5.72 59
2025 Q3 5,711,143 $38,948,604 -$190,967 $6.82 62
2025 Q2 5,608,393 $50,360,042 -$1,967,737 $8.98 61
2025 Q1 5,927,266 $31,887,300 -$1,903,352 $5.38 70
2024 Q4 6,273,891 $46,738,246 +$1,465,553 $7.45 66
2024 Q3 6,043,039 $54,690,941 -$941,259 $9.04 74
2024 Q2 6,048,765 $64,235,639 +$10,026,682 $10.62 70
2024 Q1 5,150,472 $45,375,589 +$1,441,086 $8.81 60
2023 Q4 5,013,719 $34,190,882 +$1,682,466 $6.82 53
2023 Q3 4,669,553 $45,574,879 +$5,098,401 $9.76 49
2023 Q2 4,172,822 $20,195,823 -$556,186 $4.84 31
2023 Q1 4,274,553 $17,182,141 +$80,314 $4.02 27
2022 Q4 4,237,358 $16,355,291 +$422,170 $3.86 29
2022 Q3 4,140,684 $19,915,939 -$1,043,988 $4.81 24
2022 Q2 4,369,230 $20,015,834 -$541,140 $4.55 24
2022 Q1 4,497,986 $24,151,616 -$1,058,805 $5.37 27
2021 Q4 4,689,456 $28,326,877 -$1,956,325 $6.04 28
2021 Q3 4,937,278 $35,111,639 -$858,297 $7.09 37
2021 Q2 5,038,104 $42,378,665 -$4,335,936 $8.38 48
2021 Q1 5,558,891 $46,034,445 +$4,679,250 $8.28 54
2020 Q4 5,363,782 $34,704,477 -$1,508,376 $6.47 47
2020 Q3 5,573,496 $32,891,003 -$1,111,394 $5.90 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .